![Hagit Binder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 236 671 $ al 31/07/2026
Hagit Binder currently works at Neurosense Therapeutics Ltd., as Chief Operating Officer from 2023.
Ms. Binder also formerly worked at Nextar Chempharma Solutions Ltd., as Vice President-Projects & Marketing from 2018 to 2022.
Ms. Binder received her undergraduate degree, graduate degree, and Masters Business Admin degree from Bar-Ilan University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/03/2026 | 508.970 ( 1,44 % ) | 236 671 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Director de Operaciones | 01/05/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Nextar Chempharma Solutions Ltd.
 Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Ventas & Marketing | 01/01/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Bar-Ilan University
 Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nextar Chempharma Solutions Ltd.
Nextar Chempharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Neurosense Therapeutics Ltd.
 Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
